[ Ref ID: 39 ] Address - GB -London,
It is very worrying to encounter disturbing news / cases on clinical trials not following ethically to the compliance given. Though we always knew (few notes below):
- All medicines are subject to rigorous testing before they are approved by regulatory authorities (such as the US Food and Drug Administration).
- All clinical studies in pharmaceutical companies are conducted in compliance with international guidelines according to Good Clinical Practice (GCP) and must be approved by regulatory authorities and Ethics Committees or local Institutional Review Boards.
:
These boards ensure that proposed trials are acceptable, that participants are fully informed about the benefits and risks related to the trials and that the healthcare professionals who run the trials (called “investigators”) take appropriate actions to protect patients from any harm. For further information, see responsible R&D.
- During each phase of the clinical trials for a medicine, Global Drug Safety Department evaluates the safety and effectiveness to determine the benefit–risk profile of the medicine. If the risk exceeds the patient benefit, then pharmaceutical companies will change the study or halt development of that medicine.
The 3 days event includes a pre-conference dinner on day one, giving delegates and organisations invaluable networking opportunities. The 2 days program are designed to provide practical and exciting case studies that encouraged participants to bring along any burning questions and challenges that exist within their organisation for discussions.
Topic discussed includes:
1) Ethical and regulatory compliance
2) 0utlines key regulations / laws that related to ethical behaviour in all aspects of the pharmaceutical industry. The outcome is to promote ethical and compliant behaviour, patient safety and wellbeing, patient dignity and privacy, data integrity, and transparency; describe the impact of ethics and compliance on the pharmaceutical industry
3) The impact of non-compliance and many more.
This meeting is geared for CRO’s, VP’s, Directors, Senior Researchers, Heads, Group Leaders, Scientists, Specialists, Experts and PhD’s from:
• Clinical Research and Development
• Clinical Research Services
• Clinical Data Management
• Clinical Study Design
• Clinical Pharmacology
• Medical / Scientific Affairs
• Safety Surveillance
• Product Development
• Marketing/Sales
• Projected Management
• Healthcare Professionals
• Licensing and Partnering
• Consultants
• Patient Recruitment Companies
• Contract Research Organisations
• Regulatory Affairs
• Associations / Institutions
Participation Price:
For more information about the price please call us tel:+421 944 263926